Connect with us

Technology

Fusion Was a Punchline – General Fusion Heated Plasma to 8.4 Million Degrees by Squeezing It

Published

on

Issued on behalf of General Fusion Inc.

In a single stretch of 2026, General Fusion was named the world’s top GreenTech company by TIME, reported heating plasma to millions of degrees in its innovative demonstration machine, signed a framework to bring fusion power to the Italian grid, and advanced toward becoming the first publicly traded pure-play fusion company.

Equity Insider News Commentary

Key Takeaways

General Fusion Inc. was ranked the world’s #1 GreenTech company of 2026 by TIME (in partnership with Statista), topping a list of 250 companies with a score of 96.68, selected from more than 8,300 applicants worldwide.The company says its world-first Lawson Machine 26 (“LM26”) demonstration machine, operating since early 2025, heated plasma to roughly 8.4 million degrees Celsius by mechanically compressing it, a step toward the milestones required for practical Magnetized Target Fusion.General Fusion signed a framework agreement with Renexia S.p.A. to explore deploying its fusion technology in Italy, an early move from the laboratory toward the commercial power grid.The company is advancing toward becoming the first publicly traded pure-play fusion company through a proposed business combination with Spring Valley Acquisition Corp. III (NASDAQ: SVAC), expected to trade on the Nasdaq under the ticker “GFUZ” upon consummation of the transaction.The move arrives as next-generation energy names, including NuScale Power Corporation (NYSE: SMR), Oklo (NYSE: OKLO), NANO Nuclear Energy (NASDAQ: NNE), and Centrus Energy (NYSE: LEU), draw investor attention amid AI-driven electricity demand.

From Punchline to Proof Points

VANCOUVER, BC, June 30, 2026 /CNW/ — For half a century, commercial fusion has carried a punchline: it is always “twenty years away.” The physics is the closest thing humanity has to a perfect energy source. It is the reaction that powers the sun, fueled by hydrogen, producing no carbon emissions and no long-lived radioactive waste, but turning it into electricity on the grid has defeated generations of scientists. What has changed for General Fusion Inc. is that, across a remarkable run in 2026, the Vancouver-based company has begun replacing the punchline with proof points: a top global ranking, an operating demonstration machine posting real results, a first step toward the commercial grid, and a path to the public markets. Taken together, they reframe a decades-old “someday” into a story built on milestones, hardware, and execution.

 

 

A No. 1 Ranking That Signals Credibility

The headline acknowledgment came from TIME. On June 9, 2026, General Fusion was ranked number one on TIME’s list of the World’s Top GreenTech Companies of 2026, produced in partnership with Statista. The company topped a field of 250 ranked companies with a score of 96.68, selected from more than 8,300 applicants worldwide. The company said the recognition reflects both the innovation behind its fusion technology and the execution it has shown as it pushes toward commercialization.

That kind of outside signal matters in a field as hard to handicap as fusion. The opportunity is enormous if anyone can deliver reliable, zero-carbon baseload electricity at scale, but the sector has spent decades burdened by long timelines and skepticism. A high-profile ranking does not solve the engineering challenge, but it does provide a credible third-party marker that General Fusion is being taken seriously as one of the leading names in the field. “Being named TIME’s top GreenTech company of 2026 is a testament to the incredible work of our team and a recognition of our innovative approach to transforming the world’s energy supply through fusion energy,” said General Fusion CEO Greg Twinney, while emphasizing that practical fusion will depend on disciplined investment and a clear path to commercialization.

The Big Idea: Magnetized Target Fusion

Most fusion approaches that make headlines fall into two camps: massive tokamaks that use powerful superconducting magnets to confine superheated plasma, or laser-driven systems that implode tiny fuel pellets. Both are scientifically remarkable, and both are extraordinarily expensive and complex. General Fusion is pursuing a different path, Magnetized Target Fusion, or MTF, designed to achieve fusion without relying on either banks of high-powered lasers or large superconducting magnets. Instead, the approach mechanically compresses magnetized plasma, which the company argues can be done with more conventional, durable materials and at lower cost.

That practical-engineering angle is central to the investment story. Fusion has always captured attention because of its potential to deliver clean, abundant energy, but General Fusion’s pitch is that the winner may not be the company with the most elegant physics on paper. It may be the one that can build something durable, repeatable, and economically viable enough to plug into the real-world power system.

LM26: The Machine and the 8.4-Million-Degree Result

The company’s central proof point is hardware, not just theory. In early 2025, General Fusion said it designed, built, and began operating its world-first MTF demonstration machine, Lawson Machine 26, or LM26, in under two years, describing it as the first MTF demonstration machine built at a commercially relevant scale. According to the company, LM26 mechanically compresses plasma with a lithium liner at 50% commercial-scale diameter based on current design parameters.

In 2026, the program produced a tangible result that gives the story physical substance: General Fusion reported that, by mechanically squeezing the plasma, LM26 heated it to approximately 8.4 million degrees Celsius (on the order of 0.72 keV), reporting a more-than-threefold increase in plasma electron temperature through compression. The company has framed LM26’s roadmap as a sequence of milestones: plasma heating to 1 keV, then 10 keV, and ultimately the Lawson criterion, the combination of conditions needed to produce net fusion energy in the plasma. That sequence is what turns an abstract ambition into a trackable series of technical checkpoints. It does not remove the technical risk, but it gives the story a far more tangible shape than concept slides alone.

Advancing Towards Commercial Deployment: The Renexia Framework in Italy

If LM26 is the proof that the physics is advancing, General Fusion’s framework agreement with Italy’s Renexia S.p.A. is the first visible step toward where fusion ultimately has to land: the commercial power grid. Renexia, part of the Toto Group, is an Italian renewable-energy developer, and the framework agreement contemplates exploring the deployment of General Fusion’s magnetized target fusion technology in Italy through a milestone-based, multi-phase approach. The company has described the arrangement as a framework, a structured but non-binding step, rather than a final construction contract.

Still, the strategic signal is meaningful. Moving from a demonstration machine in British Columbia toward a named commercial-deployment pathway in Europe is exactly the kind of progression a fusion developer needs to show if it wants investors to believe the technology has the potential to travel from the laboratory to the energy market. “This agreement with Renexia represents another meaningful step toward exporting our practical fusion energy technology, developed in Canada, to the world,” General Fusion’s leadership framed the effort, while Renexia’s management pointed to fusion’s potential role in Italy’s long-term decarbonization. As with every milestone here, execution over time, not the announcement itself, is what will ultimately matter.

The Public-Markets Path: A Roughly US$1 Billion Transaction

What turns this from a science story into a market story is the deal. In January 2026, General Fusion entered into a business combination agreement with Spring Valley Acquisition Corp. III (NASDAQ: SVAC), a special-purpose acquisition company focused on power infrastructure and decarbonization. The transaction implies an approximately US$1 billion pro-forma equity value, inclusive of a roughly US$108 million committed and oversubscribed PIPE financing and up to US$230 million of Spring Valley’s trust capital, assuming no redemptions. If completed, the company says the combined entity would trade on the Nasdaq under the ticker “GFUZ,” making General Fusion, by its account, the first publicly traded pure-play fusion company, a milestone that could bring a new class of retail investors into a sector that has largely remained private.

There is notable pedigree on the sponsor side. The Spring Valley team has, by its own account, raised roughly US$920 million across four IPOs over five years, and one of its earlier vehicles previously completed the business combination that took small-modular-reactor developer NuScale Power Corporation public, placing the General Fusion transaction in a recognizable clean-energy SPAC lineage. That pedigree should be weighed against the inherent risks of any pre-revenue, pre-commercialization business going public through a SPAC, a structure where outcomes depend on closing conditions, redemptions, financing, and a long road of technical execution still ahead. The transaction remains subject to shareholder and regulatory approvals and customary closing conditions, as detailed in the SEC filings referenced below.

The Demand Backdrop: Why Fusion’s Moment May Be Arriving

The context behind all of this is a once-in-a-generation surge in electricity demand. The International Energy Agency has projected global electricity demand could grow on the order of 40% to 50% by 2035, driven by artificial-intelligence data centers, broad electrification, and industrial growth. That is not a gentle increase; it is a structural step-change forcing utilities, governments, and technology giants to hunt for new sources of firm, clean, baseload power, the kind that runs day and night regardless of weather. Fusion is the ultimate prize in that search: unlike fission, it does not rely on splitting heavy atoms or produce the same long-lived waste; unlike wind and solar, it is not intermittent. The collision of soaring demand and abundant capital has pulled next-generation energy toward the public markets and opened the door even to pre-revenue developers.

The Next-Generation Energy Names Investors Are Watching

General Fusion would be a genuine rarity as a publicly traded pure-play fusion company. There are almost no direct listed comparisons, which is part of the appeal and part of the risk. In practice, the market tends to group fusion with the broader advanced-nuclear and next-generation energy trade, where a handful of public names serve as proxies for investor enthusiasm. The following comparisons are provided for illustrative and contextual purposes only; these companies pursue different technologies, are at different stages, and several are far larger and more established than a pre-revenue fusion developer. Investors should not assume General Fusion will achieve comparable results, valuations, or outcomes.

NuScale Power Corporation (NYSE: SMR) is the most directly relevant reference point, and not only as one of the best-known public proxies for next-generation nuclear. NuScale was itself taken public through an earlier Spring Valley business combination, the same sponsor family now behind the General Fusion transaction. As a small-modular-reactor developer with a U.S. Nuclear Regulatory Commission-approved design, it has reported roughly US$1 billion in liquidity in early 2026 and continued progress on large U.S. deployment programs. Oklo Inc. (NYSE: OKLO) has become one of the most visible advanced-nuclear names, pursuing compact fast-reactor designs and working through NRC licensing with ambitions to bring a commercial unit online later this decade.

NANO Nuclear Energy Inc. (NASDAQ: NNE) rounds out the advanced-reactor cohort as a closely watched microreactor and advanced-fission developer, an earlier-stage, smaller-capitalization name illustrating the breadth of investor appetite, and the volatility, across the advanced-energy spectrum. Centrus Energy Corp. (NYSE: LEU) approaches the theme from the fuel-supply side, producing and seeking to expand domestic enrichment capacity, including the high-assay low-enriched uranium (HALEU) many advanced reactors will require, a “picks-and-shovels” angle on the build-out. These companies are referenced to illustrate the sector and do not imply any partnership, endorsement, affiliation, or comparable financial performance.

Why This Story Can Travel

The reason this General Fusion story resonates is that it taps several narratives at once: a clean-energy story, a climate story, an AI-power-demand story, a commercialization story, and a public-markets story, all in one. Crucially, the company frames fusion as an engineering and execution challenge, not a guaranteed breakthrough, a balance that keeps the narrative grounded while preserving what makes fusion compelling in the first place. For investors who have spent years hearing that fusion is always two decades away, the past several months offer a cleaner framework for following the story: outside recognition from TIME, a named machine posting real temperature results, a first commercial-deployment framework in Europe, and a defined route toward the public markets. That does not make the company low-risk. Fusion remains one of the hardest technical and commercial challenges in the world, and General Fusion’s own cautionary language makes that clear. But it is one of the more concrete and visible fusion narratives currently developing.

What to Watch From Here

For investors tracking the story, the near-term markers are clear: the progress of the LM26 program against its next temperature milestones; the development of the Renexia framework in Italy from framework toward defined project phases; and the path of the proposed business combination with Spring Valley Acquisition Corp. III through its remaining shareholder and regulatory steps toward a targeted mid-2026 close. The substance behind the story is the technical execution; the market mechanism is the transaction. Both will be tested in the months ahead, and whether or not fusion finally beats its decades-old reputation, General Fusion has put itself, and soon potentially public investors, at the center of the attempt. More on the company’s technology and approach is available on the General Fusion homepage.

SIGNAL OVER NOISE

Signal over noise. Fusion, advanced-nuclear, and clean-energy headlines move fast, and the crowd often moves first. Eagle Eye is a real-time investor signal-intelligence platform that surfaces sentiment shifts, news flow, and trending tickers as they happen, so you see the move forming instead of reading about it later. See it at eagle-eye.dev.

CONTACT
Equity Insider
info@equity-insider.com
(604) 265-2873

SOURCES

[1] General Fusion Inc., “General Fusion Named World’s Top GreenTech Company of 2026 by TIME” (June 9, 2026; TIME #1 ranking, score 96.68, LM26, SVAC combination, CEO Greg Twinney).
[2] General Fusion Inc. / Spring Valley Acquisition Corp. III, “General Fusion to Become First Publicly Traded Pure-Play Fusion Company…” (January 22, 2026; ~US$1B equity value, PIPE, trust, mid-2026 close, GFUZ ticker).
[3] General Fusion Inc., LM26 compressional-heating results (2026; plasma heated to ~8.4 million °C / ~0.72 keV via mechanical compression; milestone roadmap).
[4] General Fusion Inc., framework agreement with Renexia S.p.A. (Toto Group) to explore fusion deployment in Italy (2026).
[5] TIME, “World’s Top GreenTech Companies of 2026” (June 9, 2026, in partnership with Statista).
[6] International Energy Agency, global electricity-demand projections (cited for ~40-50% growth by 2035).

Disclaimer:

This article is a paid digital media distribution and is for informational purposes only. It is not financial, investment, or trading advice, and is neither an offer nor a recommendation to buy or sell any security. Readers should conduct their own due diligence and consult a licensed financial advisor before making investment decisions. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice, nor are we licensed under U.S. or Canadian securities laws. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Nothing in this publication should be considered as personalized financial advice, and no communication by our employees to you should be deemed as personalized financial advice. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

USA News Group is a wholly-owned subsidiary of Market IQ Media Group Limited, a company incorporated under the laws of Ireland (“MIQL”). This article is being distributed by USA News Group on behalf of MIQL. MIQL, in turn, has been paid a fee for advertising and digital media by Creative Direct Marketing Group (“CDMG”). CDMG has been retained by General Fusion, pursuant to a services agreement, to provide various marketing and advertising services for an aggregate fee. This article was prepared and published pursuant to that services agreement. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this article or email as the basis for any investment decision. MIQL does not own shares of General Fusion Inc. or Spring Valley Acquisition Corp. III (Nasdaq: “SVAC”) but reserves the right to buy and sell shares of the company at any time. We also expect further compensation as an ongoing digital media effort to increase visibility for the company. This disclaimer serves as notice that all material disseminated by MIQ has been reviewed and approved on behalf of General Fusion Inc. by CDMG; this is a paid digital media distribution.

Cautionary Note Regarding Forward-Looking Statements

Certain statements included in this document are not historical facts but are forward-looking statements. All statements other than statements of historical facts contained in this document are forward-looking statements. Any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are also forward-looking statements. In some cases, you can identify forward-looking statements by words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “strategy,” “future,” “opportunity,” “may,” “target,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” “preliminary,” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements include, without limitation, statements regarding the potential benefits of the framework agreement with Renexia S.p.A. (“Renexia”), including its potential to support Italy’s decarbonization and energy transition objectives and to serve as a means of exporting General Fusion’s technology; the settlement and execution of definitive agreements for future stages of the work program contemplated under the agreement; the intended roles and contributions of Renexia and General Fusion; the possible siting, development, funding, construction, and commissioning of one or more MTF power plants, including the evaluation, selection, and potential use of a site; the closing of the transactions (the “Proposed Business Combination”) contemplated by the business combination agreement, dated January 21, 2026, among General Fusion, Spring Valley Acquisition Corp (“SVAC”) and the other party thereto (as amended, the “Business Combination Agreement”); SVAC’s, General Fusion’s, or their respective management teams’ expectations concerning General Fusion’s plan to go public through the Proposed Business Combination and expected benefits or timing thereof; the outlook for General Fusion’s business, including its ability to commercialize MTF or any other fusion technology on its expected timeline or at all; and statements regarding the current and expected results of General Fusion’s LM26 program; as well as any information concerning possible or assumed future results of operations of General Fusion. The forward-looking statements are based on the current expectations of the management team of each of SVAC and General Fusion, as applicable, and are inherently subject to uncertainties and changes in circumstance and their potential effects. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that the General Fusion and Renexia are unable to agree on the terms of a definitive agreement for the identification and evaluation of a potential site; that General Fusion and Renexia are unable to complete due diligence and the acquisition or leasing of any proposed site; that General Fusion and Renexia are thereafter unable to agree on the scope, timing, budgets and other terms for the development, permitting, funding, construction, and commissioning of an MTF power plant in Italy; that General Fusion and Renexia are unable to negotiate and enter into definitive agreements with third parties in connection with the funding, permitting, construction, commissioning, and operation of an MTF power plant in Italy; that General Fusion and Renexia are unable to secure required capital, permits, approvals, equipment, and services; that demand, interest, and the regulatory environment for fusion energy in Italy develop in a manner adverse to the objectives of the agreement; that the Proposed Business Combination may not be completed in a timely manner or at all, which may adversely affect the price of SVAC’s securities; the risk that the conditions to the consummation of the Proposed Business Combination, including the adoption of the Business Combination Agreement by the shareholders of SVAC and General Fusion and the receipt of regulatory approvals are not satisfied or waived; the risk that there occurs any event, change or other circumstance that could give rise to the termination of the Business Combination Agreement; the risk that the announcement or pendency of the Proposed Business Combination has a negative effect on General Fusion’s business relationships, performance, and business generally; the risk that the Proposed Business Combination disrupts current plans of General Fusion and potential difficulties in its employee retention as a result of the Proposed Business Combination; the risk of legal proceedings against General Fusion or SVAC related to the Proposed Business Combination; the risk that the anticipated benefits of the Proposed Business Combination are not realized; the risk that the combined entity is unable to maintain the listing of SVAC’s securities or to meet listing requirements and maintain the listing of the combined company’s securities on Nasdaq; the risk that the Proposed Business Combination may not be completed by SVAC’s business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by SVAC; the risk that the price of the combined entity’s securities may be volatile due to a variety of factors, including changes in laws, regulations, technologies, natural disasters, national security tensions, and macro-economic and social environments affecting its business; the risk of changes in the laws and regulations governing General Fusion’s research and development activities; the risk that General Fusion fails to commercialize MTF on the expected timeline or at all, including any failure to achieve the objectives of the LM26 program; the risk of the effects of climate change, extreme weather events, water scarcity, and seismic events, and that strategies to deal with these issues are not effective; the risk that sufficient demand for fusion energy does not develop or takes longer to develop than anticipated; the risk of fluctuations in currency markets; the risk that General Fusion is unable to complete and successfully integrate any future acquisitions; the risk of increased competition in the fusion industry; the risk of supply chain disruptions and that materials are in limited supply; and the risk that the proposed private placement of convertible preferred shares and warrants by General Fusion (the “PIPE Financing”) may not be completed, or that other capital needed by the combined company may not be raised on favorable terms, or at all, including as a result of the restrictions agreed to in connection with the PIPE Financing. The foregoing list is not exhaustive, and there may be additional risks that neither General Fusion nor SVAC presently know or that SVAC and General Fusion currently believe are immaterial. You should carefully consider the foregoing factors, any other factors discussed herein and in the other filings and potential filings by General Fusion, SVAC, or the combined company resulting from the proposed transaction with the U.S. Securities and Exchange Commission (the “SEC”), including those described under the heading “Risk Factors.”

General Fusion and SVAC caution you against placing undue reliance on forward-looking statements, which reflect current beliefs and are based on information currently available as of the date a forward-looking statement is made. Forward-looking statements set forth in this document speak only as of the date of this document. Neither General Fusion nor SVAC undertakes any obligation to revise forward-looking statements to reflect future events, changes in circumstances, or changes in beliefs, except as required by applicable securities laws. In the event that any forward-looking statement is updated, no inference should be made that General Fusion or SVAC will make additional updates with respect to that statement, related matters, or any other forward-looking statements.

Important Information for Investors and Shareholders

In connection with the Proposed Business Combination, General Fusion and SVAC jointly filed with the SEC a registration statement on Form F-4 (the “Registration Statement”), which includes a preliminary prospectus with respect to SVAC’s securities to be issued in connection with the Proposed Business Combination and a preliminary proxy statement in connection with SVAC’s solicitation of proxies for the vote by SVAC’s shareholders with respect to the Proposed Business Combination and other matters described in the Registration Statement. On June 12, 2026, the SEC declared the Registration Statement effective and SVAC filed the definitive Proxy Statement/Prospectus (the “Proxy Statement/Prospectus”) with the SEC. SVAC mailed copies of the Proxy Statement/Prospectus to SVAC’s shareholders as of the record date of June 12, 2026. Before making any investment or voting decision, investors and security holders of SVAC and General Fusion are urged to read the Proxy Statement/Prospectus, and any amendments or supplements thereto, as well as all other relevant materials filed or that will be filed with the SEC in connection with the Proposed Business Combination as they become available because they will contain important information about General Fusion, SVAC and the Proposed Business Combination. Investors and security holders are able to obtain free copies of the Registration Statement, the Proxy Statement/Prospectus and all other relevant documents filed or that will be filed with the SEC by SVAC through the website maintained by the SEC at www.sec.gov. In addition, the documents filed by SVAC may be obtained free of charge from SVAC’s website at https://sv-ac.com or by directing a request to Spring Valley Acquisition Corp. III, Attn: Corporate Secretary, 2100 McKinney Avenue, Suite 1675, Dallas, Texas 75201. The information contained on, or that may be accessed through, the websites referenced in this document is not incorporated by reference into, and is not a part of, this document.

Participants in the Solicitation

General Fusion, SVAC and their respective directors, executive officers and other members of management and employees may, under the rules of the SEC, be deemed to be participants in the solicitations of proxies from SVAC’s shareholders in connection with the Proposed Business Combination. For more information about the names, affiliations and interests of SVAC’s directors and executive officers, please refer to the Proxy Statement/Prospectus and the Registration Statement, Proxy Statement and other relevant materials filed or to be filed with the SEC in connection with the Proposed Business Combination when they become available. Shareholders, potential investors and other interested persons should read the Proxy Statement/Prospectus carefully before making any voting or investment decisions. You may obtain free copies of these documents from the sources indicated above.

No Offer or Solicitation

This document shall not constitute a “solicitation” as defined in Section 14 of the Securities Exchange Act of 1934, as amended. This document shall not constitute an offer to sell or exchange, the solicitation of an offer to buy or a recommendation to purchase, any securities, or a solicitation of any vote, consent or approval, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale may be unlawful under the laws of such jurisdiction. No offering of securities in the Proposed Business Combination shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended, or an exemption therefrom.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fusion-was-a-punchline—general-fusion-heated-plasma-to-8-4-million-degrees-by-squeezing-it-302814644.html

Continue Reading

Technology

Amid Rising Costs and Surgical Disruptions in ASCs, NorthStar Anesthesia Strengthens Focus on ASC Partnerships

Published

on

By

With 17 new ASC partnerships nationwide to date in 2026, NorthStar Anesthesia emphasizes proactive patient assessment, reliable staffing, and clinical consistency to help surgery centers reduce preventable cancellations and maximize surgical capacity.

IRVING, Texas, Oct. 23, 2026 /PRNewswire/ — As ambulatory surgery centers (ASCs) face mounting financial pressures, staffing challenges, and increasingly complex patient needs, anesthesia has emerged as a critical partner in their ability to operate efficiently and sustainably. NorthStar Anesthesia is addressing these challenges through a dedicated ASC model designed to reduce preventable case cancellations, improve surgical throughput, and help centers make the most of their existing operating room capacity.

NorthStar celebrates 17 new ASC partnerships nationwide to date in 2026.

“The challenge for ASCs today isn’t simply finding anesthesia coverage. It’s ensuring that coverage translates into reliable surgical capacity,” said Cindy Myers, Vice President of ASC Operations at NorthStar Anesthesia. “When cases are cancelled unnecessarily or operating rooms aren’t running as planned, the impact extends well beyond the anesthesia department. Our focus is on helping centers address those challenges systematically, so they can deliver more consistent care and operate more efficiently.”

Reducing Preventable Cancellations Through Better Preparation

One of the most significant opportunities to improve ASC performance lies in the preoperative process. When potential anesthesia concerns are not identified until the day of surgery, patients may face unexpected cancellations, surgeons lose valuable operating time, and centers absorb the cost of unused capacity.

NorthStar addresses this challenge through ASC-specific pre-anesthesia testing (PAT) guidelines and standardized clinical protocols designed to identify potential issues earlier, facilitate appropriate patient optimization, and support consistent decision-making across the surgical process.

“In ambulatory surgery, the decisions made before the patient arrives are often just as important as those made in the operating room,” said Gajan Mahendran, MD, Vice President of Physician Services at NorthStar Anesthesia. “A consistent, evidence-based approach to preoperative assessment helps us identify risks earlier, determine which patients are appropriate for the ASC setting, and address potential barriers to surgery in advance. That means fewer last-minute surprises and a better experience for patients, surgeons, and facilities.”

Aligning Anesthesia Resources With Surgical Demand

Alongside clinical challenges, ASCs are navigating a changing economic environment. In a recent Becker’s ASC Review interview, NorthStar CEO Adam Spiegel noted that approximately 80% of ASCs in NorthStar’s network now require anesthesia stipends, compared with just 10% to 15% before the pandemic.

As anesthesia costs rise, ensuring that staffing levels align with actual surgical demand has become increasingly important. NorthStar works with ASC partners to develop staffing models that reflect each facility’s case mix, surgical volume, and operating requirements. “Adding anesthesia resources doesn’t automatically improve performance if those resources aren’t aligned with the center’s surgical volume,” Myers said. “We work closely with our partners to understand their schedules, case mix, and operational needs so we can build a model that supports both reliable access to care and financial sustainability.”

Combining National Resources With Local Clinical Expertise

As ASCs take on a greater share of surgical procedures, the demands placed on anesthesia providers are becoming more complex. Smaller or locally managed anesthesia groups may face challenges maintaining consistent coverage, recruiting clinicians, or investing in standardized clinical and operational processes.

NorthStar’s model combines local clinical leadership with national recruiting capabilities, dedicated ASC operations expertise, and established quality guidelines. This infrastructure helps support continuity of care, consistent clinical practices, and the flexibility to respond to changes in surgical demand.

The approach is reflected in NorthStar’s expanding ASC partnerships.  To date in 2026 alone, NorthStar has added 17 ASC partnerships, including CarePlex Orthopaedic Ambulatory Surgery Center in Norfolk, Virginia; Stony Point Surgery Center and West Creek Surgery Center, both part of MedRVA Healthcare in Richmond, Virginia; an Orthopedic Surgery Center in Wisconsin; Eye Surgery Center of Homewood in Homewood, Alabama; and The Toledo Clinic ASC in Toledo, Ohio.

These partnerships reflect the growing importance of anesthesia providers that can address both the clinical and operational needs of outpatient surgery centers.

To learn more and to request a confidential anesthesia program assessment, please contact James Bagliani, Director of Business Development, NorthStar Anesthesia at james.bagliani@northstaranesthesia.com. 

About NorthStar Anesthesia

NorthStar Anesthesia is a company of caregivers, founded by an anesthesiologist and a Certified Registered Nurse Anesthetist (CRNA). With more than 4,000 anesthesiologists and CRNAs under its banner, NorthStar partners with more than 280 healthcare client sites across more than 20 states and counting to deliver a more productive and efficient model of anesthesia care. Its care team approach focuses on the provision of high-quality care while measurably improving operating room performance.

Media Contact: James Bagliani, Director of Business Development, NorthStar Anesthesia james.bagliani@northstaranesthesia.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/amid-rising-costs-and-surgical-disruptions-in-ascs-northstar-anesthesia-strengthens-focus-on-asc-partnerships-302918226.html

SOURCE NorthStar Anesthesia

Continue Reading

Technology

Dimethylaminopropylamine Market to Reach USD 731.9 Million by 2035 on Surfactant and Epoxy Demand, Credence Research Finds

Published

on

By

LONDON, Oct. 23, 2026 /PRNewswire/ — Credence Research Inc. has added the “Dimethylaminopropylamine Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2035” study to its market intelligence portfolio. The report examines market value, segmentation, demand drivers, regional dynamics, competition and recent industry developments.

The dimethylaminopropylamine (DMAPA) market was valued at USD 452.6 million in 2025 and is projected to reach USD 731.9 million by 2035, representing a 4.92% compound annual growth rate over 2025–2035, according to Credence Research. The firm estimates 2026 revenue at USD 474.3 million. Asia Pacific accounted for the largest modeled geographic share at 44.0% in 2025, while Asia Pacific is projected to grow fastest at 5.88% annually. Market sizes, regional shares and segment shares are Credence Research estimates rather than independently audited industry totals.

Key Takeaways

The market is forecast to increase from USD 452.6 million in 2025 to USD 731.9 million by 2035, with a reported CAGR of 4.92%.Asia Pacific led the modeled 2025 geography with 44.0%; Asia Pacific has the fastest forecast geographic growth of 5.88%.By application, Surfactants accounted for 61.0% of modeled 2025 value, while Epoxy curing agents is forecast to grow at 5.66% a year.By end-use industry, Personal care and cosmetics accounted for 44.0% of modeled 2025 value, while Paints, coatings and composites is forecast to grow at 5.61% a year.The market definition excludes adjacent product or transaction value where that spending is outside the report’s measured scope.

Scope & Segmentation – Dimethylaminopropylamine Market

The study values sales of 3-(dimethylamino)-1-propylamine, an amine intermediate produced from dimethylamine and acrylonitrile. Included uses span betaine and amine-oxide surfactants, epoxy curing agents, polyurethane catalysts, water treatment chemicals, agrochemical intermediates and lubricant additives. Finished surfactants, coatings and other downstream products are excluded from the DMAPA revenue estimate.

By application: Surfactants (betaines and amine oxides); Epoxy curing agents; Polyurethane catalysts; Water treatment chemicals; Agrochemical intermediates; Fuel and lubricant additives; Others.By end-use industry: Personal care and cosmetics; Home care and institutional cleaning; Paints, coatings and composites; Water treatment; Agriculture; Automotive and lubricants.By geography: Asia Pacific; Europe; North America; Latin America; Middle East and Africa.

Read the complete report and request a sample: https://www.credenceresearch.com/report/dimethylaminopropylamine-market 

Why This Report Matters

The study distinguishes a narrowly defined revenue pool from adjacent activity that can inflate comparisons between research estimates. This helps strategy teams compare suppliers, customer budgets and product categories on a consistent basis.The base-year segment mix identifies where current purchasing is concentrated, while the modeled faster-growing categories help evaluate investment timing and market entry.Geographic shares are proprietary estimates; company and regulatory announcements are used to explain demand mechanisms, not to independently verify global market totals.

Market Overview
The study values sales of 3-(dimethylamino)-1-propylamine, an amine intermediate produced from dimethylamine and acrylonitrile. Included uses span betaine and amine-oxide surfactants, epoxy curing agents, polyurethane catalysts, water treatment chemicals, agrochemical intermediates and lubricant additives. Finished surfactants, coatings and other downstream products are excluded from the DMAPA revenue estimate.

DMAPA is a building block for cocamidopropyl betaine and related surfactants used in shampoos, body washes and dishwashing products. Producers serving consumer brands require consistent quality and supply, so the largest application tends to support repeat orders rather than episodic equipment-style purchases.

The outlook reflects expected changes in customer adoption, procurement, technology and regulation. It should be read as a modeled scenario, not as a guarantee of sales or company performance.

Key Attributes

Attribute

Details

Base year

2025

Historical reference

2018–2025

2025 market size

USD 452.6 million

2026 estimate

USD 474.3 million

2035 market forecast

USD 731.9 million

Reported CAGR

4.92% (2025–2035)

Geographic scope

Global

Primary source

https://www.credenceresearch.com/report/dimethylaminopropylamine-market

Segmentation

By application
The study divides this category into surfactants (betaines and amine oxides); epoxy curing agents; polyurethane catalysts; water treatment chemicals; agrochemical intermediates; fuel and lubricant additives; others. Surfactants led the 2025 value mix with 61.0%. Epoxy curing agents is the fastest-growing modeled subsegment at 5.66% a year. These shares represent Credence Research model outputs, not audited supplier sales.

By end-use industry
The study divides this category into personal care and cosmetics; home care and institutional cleaning; paints, coatings and composites; water treatment; agriculture; automotive and lubricants. Personal care and cosmetics led the 2025 value mix with 44.0%. Paints, coatings and composites is the fastest-growing modeled subsegment at 5.61% a year. These shares represent Credence Research model outputs, not audited supplier sales.

Market Growth Drivers

Mild cleansing formulas sustain high-volume demand
DMAPA is a building block for cocamidopropyl betaine and related surfactants used in shampoos, body washes and dishwashing products. Producers serving consumer brands require consistent quality and supply, so the largest application tends to support repeat orders rather than episodic equipment-style purchases.

Epoxy hardeners provide a faster-growth outlet
DMAPA-based amidoamines are used in epoxy curing systems for floors, protective coatings and composite applications. Wind blade production and industrial maintenance provide additional demand. The report models epoxy curing agents as the fastest-growing application, although their value starts below surfactants.

Capacity integration shapes producer economics
The chemical route depends on dimethylamine and acrylonitrile, making feedstock access and energy costs important. Integrated producers can manage these inputs and purity requirements more directly, while regional buyers value dependable supply and local technical support.

Regional Analysis
Asia Pacific held 44.0% of modeled 2025 revenue, while Asia Pacific is expected to record the fastest regional growth at 5.88%. The allocation follows the study’s defined buyer or provider-revenue scope.

Asia Pacific
Asia Pacific represented 44.0% of modeled 2025 market value. China hosts extensive betaine and epoxy manufacturing and new intermediate capacity. Regional performance also depends on local regulation, industrial investment and purchasing conditions.

Europe
Europe represented 23.0% of modeled 2025 market value. Specialty formulations and high-purity specifications sustain demand. Regional performance also depends on local regulation, industrial investment and purchasing conditions.

North America
North America represented 21.0% of modeled 2025 market value. Personal care, coating and water treatment buyers support a mature market. Regional performance also depends on local regulation, industrial investment and purchasing conditions.

Latin America
Latin America represented 7.0% of modeled 2025 market value. Brazilian and Mexican cleaning and personal care production expands. Regional performance also depends on local regulation, industrial investment and purchasing conditions.

Middle East and Africa
Middle East and Africa represented 5.0% of modeled 2025 market value. Industrial chemicals and water treatment provide emerging outlets. Regional performance also depends on local regulation, industrial investment and purchasing conditions.

Market Challenges

Input prices and possible overcapacity
Changes in acrylonitrile and dimethylamine costs can pressure margins. New Asian capacity could also exceed near-term demand, creating price competition, especially for producers that lack integrated feedstock or differentiated purity grades.

Handling and product-purity requirements
DMAPA is a hazardous industrial intermediate requiring careful handling. Residual amines in downstream betaines can create sensitization concerns, so cosmetics customers increasingly emphasize analytical control, specifications and supplier qualification.

Future Outlook
Asia Pacific should remain the main production and demand center, with surfactants anchoring volume and epoxy applications contributing above-average growth. Supplier positioning will depend on feedstock integration, reliable logistics, high-purity grades and the pace at which new capacity is absorbed.

Competitive Landscape
BASF and Eastman Chemical are identified as integrated DMAPA producers, while Zhangjiagang Feixiang Chemical and Zhejiang Xinhua Chemical participate in Chinese production. Huntsman is relevant to downstream amine chemistry. Solvay, Evonik and Kao are better described as converters or customers for DMAPA-based surfactants rather than direct merchant DMAPA producers. No credible company-specific DMAPA revenue ranking is available.

Key Players
BASF; Eastman Chemical; Zhangjiagang Feixiang Chemical; Zhejiang Xinhua Chemical; Huntsman (downstream derivatives); Solvay (surfactants); Evonik (surfactants); Kao (surfactants)

Recent Developments

Oct. 16, 2025: BASF said the July start-up of expanded DMAPA production in Nanjing nearly doubled the site’s annual capacity and raised BASF’s global DMAPA capacity by more than 20% to approximately 85,000 metric tons.July 2025: As part of the same Nanjing project, BASF expanded polyetheramine capacity by about 25%. This is a related amine-chain investment, not an additional DMAPA plant.

Report Coverage
The study provides market estimates for 2025 and 2035, a 2026 interim estimate, analysis of the defined product and service scope, segment and geographic revenue shares, demand drivers, technology changes, competitive roles, constraints and recent dated developments. The reported CAGR and regional shares are based on Credence Research’s market model. Company announcements are contextual evidence and should not be interpreted as independent verification of the forecast.

Read the complete report and request a sample: https://www.credenceresearch.com/report/dimethylaminopropylamine-market 

Related Reports

https://www.credenceresearch.com/report/apac-infectious-enteritis-treatment-market 

https://www.credenceresearch.com/report/australia-digital-therapeutics-market 

https://www.credenceresearch.com/report/australia-corporate-education-and-upskilling-market 

https://www.credenceresearch.com/report/prescription-drugs-market 

https://www.credenceresearch.com/report/orthopedic-devices-market 

https://www.credenceresearch.com/report/parkinsons-disease-therapeutics-market 

https://www.credenceresearch.com/report/plasma-derived-therapy-market 

https://www.credenceresearch.com/report/over-the-counter-drugs-market 

https://www.credenceresearch.com/report/orphan-drugs-market 

https://www.credenceresearch.com/report/pediatric-drugs-market 

https://www.credenceresearch.com/report/pain-management-drugs-market 

https://www.credenceresearch.com/report/osteoporosis-drugs-market 

https://www.credenceresearch.com/report/patient-monitoring-devices-market 

https://www.credenceresearch.com/report/australia-drive-by-wire-market 

https://www.credenceresearch.com/report/australia-cold-chain-and-refrigerated-transport-market 

https://www.credenceresearch.com/report/australia-critical-illness-insurance-market 

https://www.credenceresearch.com/report/asia-pacific-lysosomal-acid-lipase-deficiency-lal-d-treatment-market 

https://www.credenceresearch.com/report/australia-eco-friendly-labels-market 

https://www.credenceresearch.com/report/apac-healthcare-digital-twins-market 

https://www.credenceresearch.com/report/australia-electric-vehicle-charger-operations-and-maintenance-services-market 

https://www.credenceresearch.com/report/australia-driveline-components-market 

About Us
Credence Research Inc. is a global market intelligence and consulting firm founded in 2015. It provides quantitative market research, competitive intelligence and strategic advisory services to businesses, investors and other organizations. Its research draws on primary and secondary information, industry interviews and structured market models.

The firm analyzes market size, growth drivers, segmentation, regional opportunities, supply chains and competitive positioning across industrial, technology, energy, health care and consumer markets. Its studies help clients evaluate strategic and investment decisions with documented assumptions and industry context.

Contact Us
Credence Research Inc. 
Tower C-1105, S 25, Akash Tower
Vishal Nagar, Pimple Nilakh, Haveli, Pune 411027, India 
USA: +1-888-600-6441 
sales@credenceresearch.com 
www.credenceresearch.com 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/dimethylaminopropylamine-market-to-reach-usd-731-9-million-by-2035-on-surfactant-and-epoxy-demand-credence-research-finds-302918151.html

Continue Reading

Technology

Misty Ventures and Aplicata Technologies Announce Strategic Partnership to Pursue Canadian Defence Opportunities

Published

on

By

Together, Aplicata and Misty Ventures will leverage their respective expertise, networks, and resources to support the commercialization of innovative technologies and help bring impactful solutions to government and public-sector markets.

SASKATOON, SK, Oct. 23, 2026 /PRNewswire-PRWeb/ — Misty Ventures, the economic development arm of Mistawasis Nêhiyawak, and Aplicata Technologies, a trusted leader in high-performance computing platforms for mission-critical defence applications, today announced they have signed a Memorandum of Understanding to explore a strategic partnership focused on pursuing and strengthening Canadian defence market opportunities.

“Partnering with Misty Ventures allows us to bring our capabilities to the Canadian defence market in a way that also creates lasting economic benefit for Mistawasis Nêhiyawak. We’re excited about the opportunity to build something meaningful together.” Mohammad Darwish, CEO of Aplicata.

Aplicata and Misty Ventures have agreed to form a Saskatchewan-based joint venture to develop and commercialize electronic warfare (EW), signals intelligence (SIGINT) and intelligence, surveillance and reconnaissance (ISR) technologies for Canadian defence.

The joint venture will deliver solutions across uncrewed aerial vehicles, aircraft, ground vehicles and naval vessels, providing the Canadian Armed Forces with a decisive operational advantage through advanced, mission-critical technology. It brings together Aplicata’s engineering, manufacturing and market expertise with Misty Ventures’ business development experience and its access to skilled talent and defence markets.

A guiding principle of the partnership is to build upon the strong business acumen, entrepreneurial capacity, and strategic vision of Mistawasis Nêhiyawak and its affiliated Indigenous communities. Through this partnership, Mistawasis Nêhiyawak seeks to leverage these strengths to contribute meaningfully to Canada’s defence priorities, supporting the development of sovereign capabilities, domestic innovation, and resilient Canadian supply chains. In addition to technology licensing, Aplicata intends to support the partnership through advanced knowledge and skills development, enabling Mistawasis Nêhiyawak to further expand its participation in Canada’s defence and security ecosystem and create lasting economic opportunity.

“This partnership reflects our commitment to building long-term, sustainable economic opportunities for Mistawasis Nêhiyawak and our broader community,” said Robert Daniels, Chief Executive Officer of Misty Ventures. “By combining our experience and market reach with Aplicata’s proven technology and market expertise, we believe we can create a defence sector business that delivers real value for Canada while creating meaningful opportunities for our people.”

“Aplicata brings a long history of innovation in advanced technologies for defence,” said Mohammad Darwish, Chief Executive Officer of Aplicata Technologies. “Partnering with Misty Ventures allows us to bring our capabilities to the Canadian defence market in a way that also creates lasting economic benefit for Mistawasis Nêhiyawak. We’re excited about the opportunity to build something meaningful together.”

About Misty Ventures

Since 2015, Misty Ventures has been the economic development entity of Mistawasis Nêhiyawak, growing through strategic partnerships across Saskatchewan’s construction, mining, oil and gas, and renewable energy sectors. Misty Ventures continues to pursue investments and collaborations aligned with its vision, mission, and values.

www.mistyventures.ca

About Aplicata Technologies

Aplicata is a trusted leader in high-performance computing platforms for mission-critical defence applications. We create innovative solutions engineered for performance and reliability, delivering results our customers can depend on. Rooted in a culture of collaboration and driven by a shared sense of purpose, we serve government and commercial organizations alike, pushing the boundaries of technology to enable new possibilities.

www.aplicata.com

Media Contact

Media Relations, Aplicata Technologies, 1 (844) 250-6300, media@aplicata.com, www.aplicata.com

View original content to download multimedia:https://www.prweb.com/releases/misty-ventures-and-aplicata-technologies-announce-strategic-partnership-to-pursue-canadian-defence-opportunities-302917752.html

SOURCE Aplicata Technologies

Continue Reading

Trending